AI Radiology Acquisition Transforms Cancer Care

Azra AI acquired Thynk Health to address the 40% of cancers detected but never treated — here's why the care coordination gap matters as much as detection

The 40% of cancers we catch but never treat just got a solution.

Azra AI acquired Thynk Health, creating what may be the most comprehensive cancer care coordination platform in the market. The deal addresses a problem that has received far less attention than cancer detection: the staggering proportion of cancer findings that are identified on imaging but never make it to treatment.

📊 Studies across multiple cancer types have documented a consistent and alarming finding: a significant percentage of cancers detected on imaging — some analyses suggest 30 to 40 percent depending on cancer type and care setting — result in patients who are either never notified of the finding, never referred to the appropriate specialist, never complete the recommended diagnostic workup, or never start treatment despite a confirmed diagnosis. The failure mode is not detection. It is the care coordination gap between a positive finding and definitive treatment.

For lung cancer specifically — the cancer most …